Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.2%. By the end of trading, Boston Scientific fell $0.14 (-1.2%) to $11.58 on average volume. Throughout the day, 10,051,644 shares of Boston Scientific exchanged hands as compared to its average daily volume of 13,103,800 shares. The stock ranged in price between $11.54-$11.74 after having opened the day at $11.68 as compared to the previous trading day's close of $11.72. Other companies within the Health Services industry that declined today were: Synergetics USA ( SURG), down 10.5%, Vision-Sciences Inc (DE ( VSCI), down 7.3%, InspireMD ( NSPR), down 6.4% and Uroplasty ( UPI), down 6.2%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.8 billion and is part of the health care sector. Shares are up 106.8% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 16 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, BG Medicine ( BGMD), up 86.2%, Arrhythmia Research Technology ( HRT), up 13.9%, Navidea Biopharmaceuticals ( NAVB), up 12.0% and Edap TMS ( EDAP), up 6.8% , were all gainers within the health services industry with DENTSPLY International ( XRAY) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Quants and Charts Agree That Boston Scientific is a Buy

Quants and Charts Agree That Boston Scientific is a Buy

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

Blizzard Pounds New York, Boston as 'Bomb Cyclone' Cripples East Coast Airports

Nvidia Is 1 of 30 Well-Known Stocks That Look Ready to Abruptly Change Direction

Nvidia Is 1 of 30 Well-Known Stocks That Look Ready to Abruptly Change Direction

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)